Univariate analysis of factors involved in recurrence-free survival in 112 cases after PSM showed that the following were significant: treatment with DAAs (p = 0.0032), presence of a single tumor (p = 0.0030), and AFP levels of 10 ng/mL or lower (p = 0.0304). This evidence concerns the gene AFP and neoplasm.